Get the Stockscreener App
3.855
12.19%
-0.535
After Hours:
3.86
0.005
+0.13%
Imunon Inc stock is traded at $3.855, with a volume of 200.46K.
It is down -12.19% in the last 24 hours and down -28.21% over the past month.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
See More
Previous Close:
$4.39
Open:
$4.19
24h Volume:
200.46K
Relative Volume:
2.02
Market Cap:
$9.41M
Revenue:
$125.00K
Net Income/Loss:
$-15.75M
P/E Ratio:
-0.6286
EPS:
-6.1327
Net Cash Flow:
$-14.57M
1W Performance:
-17.98%
1M Performance:
-28.21%
6M Performance:
-64.70%
1Y Performance:
-69.84%
1-Day Range:
$3.84
$4.19
1-Week Range:
$3.84
$4.7955
52-Week Range:
$3.84
$41.22
Imunon Inc Stock (IMNN) Company Profile
Name
Imunon Inc
Sector
Industry
Phone
(609) 896-9100
Address
997 LENOX DRIVE, LAWRENCEVILLE
Compare IMNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMNN
Imunon Inc
|
3.855 | 11.07M | 125.00K | -15.75M | -14.57M | -6.1327 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Imunon Inc Stock (IMNN) Latest News
IMUNON, Inc. to Host Investor Event in New York City on November 10, 2025, Featuring Updates on Phase 3 Study of IMNN-001 for Ovarian Cancer - Quiver Quantitative
IMUNON (NASDAQ: IMNN) plans R&D Day on IMNN-001 data and OVATION 3 study update - Stock Titan
Reversal indicators forming on Imunon Inc. stockDividend Hike & Weekly High Return Stock Forecasts - newser.com
What hedge fund moves indicate for Imunon Inc. (CBO) stock2025 Dividend Review & Safe Capital Investment Plans - newser.com
Is Imunon Inc. (CBO) stock a good hedge against inflationTrade Analysis Report & Proven Capital Preservation Methods - newser.com
Combining machine learning predictions for Imunon Inc.2025 Top Decliners & Proven Capital Preservation Methods - newser.com
What machine learning models say about Imunon Inc.Market Growth Summary & AI Optimized Trade Strategies - newser.com
What makes Imunon Inc. stock attractive to growth funds2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - newser.com
Is Imunon Inc. stock a buy in volatile markets2025 Macro Impact & Technical Confirmation Alerts - newser.com
Signal strength of Imunon Inc. stock in tech scannersWeekly Market Outlook & Daily Volume Surge Trade Alerts - newser.com
Is Imunon Inc. stock cheap at current valuationPortfolio Growth Summary & Weekly High Return Stock Forecasts - newser.com
Chart based exit strategy for Imunon Inc.Trade Exit Summary & Verified Short-Term Plans - newser.com
What drives Imunon Inc CBO stock priceHead and Shoulders Patterns & High Yield Trading Plans - earlytimes.in
How Imunon Inc. (CBO) stock reacts to fiscal policies2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
Will Imunon Inc. stock deliver better than expected guidanceJuly 2025 Opening Moves & Consistent Profit Trade Alerts - newser.com
Historical volatility pattern of Imunon Inc. visualizedWeekly Profit Report & High Return Trade Guides - newser.com
Is Imunon Inc. forming a reversal pattern2025 Historical Comparison & Risk Controlled Daily Plans - newser.com
Risk vs reward if holding onto Imunon Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
Analyzing recovery setups for Imunon Inc. investorsTrend Reversal & Entry and Exit Point Strategies - newser.com
How Imunon Inc. stock compares to market leadersQuarterly Market Review & AI Enhanced Execution Alerts - newser.com
Will Imunon Inc. (CBO) stock attract long term capital inflowsJuly 2025 Trends & High Conviction Trade Alerts - newser.com
Forecasting Imunon Inc. price range with options dataJuly 2025 Technicals & Daily Entry Point Alerts - newser.com
What margin trends mean for Imunon Inc. stock2025 Winners & Losers & Capital Efficiency Focused Ideas - newser.com
Relative strength of Imunon Inc. in sector analysisJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - newser.com
Imunon Inc Stock (IMNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.50%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):